Iberdomide and Daratumumab as Maintenance Therapy After an Autologous Stem Cell Transplant for Multiple Myeloma
- Status
- RECRUITING
- Phase
- PHASE2
Clinical Trials Related to Multiple Myeloma
Related studies linked through entity extraction aliases.
AZD0305 as Monotherapy or in Combination With Anticancer Agents in Participants With Multiple Myeloma
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
Phase I/II Open Label Study of Belumosudil Mesylate Alone, and in Combination With Dexamethasone, in Patients With Relapsed/Refractory Multiple Myeloma
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
18F-Fluciclovine PET/CT in Multiple Myeloma
- Status
- RECRUITING
- Phase
- PHASE2
Teclistamab in Combination With Daratumumab for High-Risk Smoldering Myeloma: A Clinical and Correlative Phase 2 Immuno-Oncology Study (the REVIVE Study)
- Status
- RECRUITING
- Phase
- PHASE2
Individualized Dynamic Frailty-tailored Therapy (DynaFiT) in Elderly Patients With NDMM
- Status
- RECRUITING
- Phase
- N/A
Multiple Myeloma Prognostic Indices
- Status
- COMPLETED
- Phase
- N/A
Safety, Efficacy, and Pharmacokinetics of Continuous Subcutaneous Lenalidomide in Multiple Myeloma (MM)
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
A Study of CyBorD (Cyclophosphamide, Bortezomib, Dexamethasone) Plus Daratumumab in People With Monoclonal Gammopathy of Renal Significance (MGRS)
- Status
- RECRUITING
- Phase
- PHASE2
A Study of IBI3003 in Subjects With Relapsed or Refractory Multiple Myeloma
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
A Cross-sectional Study on the Positive Rate of M Protein Based on a Highly Sensitive Serum M Protein Detection Method.
- Status
- RECRUITING
- Phase
- N/A
Psychosocial Mobile Application (THRIVE-M) for Patients With Multiple Myeloma
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- NA
Population Pharmacokinetic Study Based on Quantitative Pharmacology in Patients With Lenalidomide
- Status
- COMPLETED
- Phase
- N/A
the Safety and Efficacy of SENL103 Autologous T Cell Injection
- Status
- UNKNOWN
- Phase
- EARLY_PHASE1
A Study of Talquetamab for People With Multiple Myeloma Who Have Received BCMA CAR T-Cell Therapy
- Status
- RECRUITING
- Phase
- PHASE2
Evaluation of a Pain Management Intervention Preparatory to a Future Pragmatic Trial, ASCENT Study
- Status
- COMPLETED
- Phase
- NA
Analysis of Effectiveness and Safety of Teclistamab in Relapsed and Refractory Multiple Myeloma Patients
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- N/A
Multiple Myeloma Yoga Pilot Study
- Status
- COMPLETED
- Phase
- NA
Efficacy and Safety of PEG-rhG-CSF Injection for Neutrophil Reconstitution Following AHSCT in Lymphoma/Multiple Myeloma
- Status
- UNKNOWN
- Phase
- NA
Elranatamab Post Trial Access Study for Participants With Multiple Myeloma (MM)
- Status
- RECRUITING
- Phase
- PHASE4